| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $29.4B | $28.8B | $27.1B | $27.3B | $27.3B | $7.4B | $5.9B | $5.8B |
| Cost of Revenue | $6.2B | $6.3B | $6.5B | $5.7B | $6.6B | $4.6B | $4.7B | $4.9B |
| Gross Profit | — | — | — | — | — | $5.9B | $4.1B | $4.1B |
| R&D Expense | — | — | — | — | — | — | $9.1B | $5.0B |
| SG&A Expense | $5.8B | $6.1B | $6.1B | $5.7B | $5.2B | $5.2B | $4.4B | $4.1B |
| Operating Income | $10.0B | $1.7B | $7.6B | $7.3B | $9.9B | $4.1B | $4.3B | $8.2B |
| Net Income | $8.5B | $0.5B | $5.7B | $4.6B | $6.2B | $1.6B | $2.7B | $0.0B |
| EPS (Basic) | $6.84 | $0.38 | $4.54 | $3.66 | $4.96 | $1.24 | $2.13 | $0.00 |
| EPS (Diluted) | $6.78 | $0.38 | $4.50 | $3.64 | $4.93 | $1.23 | $2.12 | $0.00 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $59.0B | $59.0B | $62.1B | $63.2B | $68.0B | $68.4B | $61.6B | $63.7B |
| Current Assets | $18.3B | $19.2B | $16.1B | $14.4B | $14.8B | $16.0B | $30.3B | $35.8B |
| Cash & Equivalents | — | — | — | $5.4B | $5.3B | $6.0B | $11.6B | $17.9B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $11.8B | $12.0B | $11.3B | $11.2B | $11.6B | $11.4B | $9.8B | $10.6B |
| Stockholders' Equity | $22.7B | $19.3B | $22.8B | $21.2B | $21.1B | $18.2B | $22.5B | $21.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.0B | $10.8B | $8.0B | $9.1B | $11.4B | $8.2B | $9.1B | $8.4B |
| Investing Cash Flow | $-4.8B | $-3.4B | $-2.3B | $-2.5B | $-3.1B | $-14.6B | $-7.8B | $14.4B |
| Capital Expenditures | $0.6B | $0.5B | $0.6B | $0.7B | $0.6B | $0.7B | — | — |
| Financing Cash Flow | $-7.7B | $-3.4B | $-5.1B | $-6.5B | $-8.9B | $0.8B | $-7.6B | $-12.3B |